Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P…
Biotechnology
US, Bellaire [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Bio-Path Holdings, Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDBio-Path Holdings, Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Bio-Path Holdings, Inc..
If you want to see a demo, head over to the financial segments of AAPL